Shanghai Pharmaceuticals Holding Co Ltd (SHSE:601607) Share Price

Company Profile

Business description
Shanghai Pharmaceuticals is the second-largest medical distributor in China by revenue. It is vertically integrated and provides healthcare services in research and development, manufacturing, distribution, and retail. As of 2024, medical distribution is the largest segment, accounting for 91.3% of total revenue. It also has coverage of 31 provinces and cities nationwide.
Contact
No. 200 Taicang Road
Shanghai Pharmaceutical Building
Shanghai200020
CHN
T: +86 2163730908
E: [email protected]
https://www.sphchina.com
Sector
Healthcare
Stock type
Defensive
Industry
Medical Distribution
Fiscal Year End
31 December 2026
Employees
49,402

Recommended

Our view on the potential for additional offers.

Esther Holloway | 11 January 2026

AI stocks flew high in 2025 despite year-end volatility. Palantir and Lam look overvalued, but opportunities remain.

Frank Lee | 11 January 2026

Eighteen months in and passive income growth has exceeded my target.

Mark LaMonica, CFA | 11 January 2026

Index	Last price	Change	% Change
All Ordinaries	9,045.90	27.80	-0.31%
CAC 40	8,362.09	118.63	1.44%
DAX 40	25,261.64	134.18	0.53%
Dow JONES (US)	49,504.07	237.96	0.48%
FTSE 100	10,124.60	79.91	0.80%
HKSE	26,231.79	82.48	0.32%
NASDAQ	23,671.35	191.33	0.81%
Nikkei 225	51,939.89	822.63	1.61%
NZX 50 Index	13,666.73	29.52	-0.22%
S&P 500	6,966.28	44.82	0.65%
S&P/ASX 200	8,717.80	29.10	-0.33%
SSE Composite Index	4,120.43	37.45	0.92%